Pediatric Study of GVHD Ppx w/o Calcineurin Inhibitors After Day60 Post First Allo HSCT for Hematological Malignancies.
St. Jude Children's Research Hospital
St. Jude Children's Research Hospital
Masonic Cancer Center, University of Minnesota
M.D. Anderson Cancer Center
City of Hope Medical Center
City of Hope Medical Center
Charite University, Berlin, Germany
Fred Hutchinson Cancer Center
Sumitomo Pharma Switzerland GmbH
City of Hope Medical Center
Therapeutic Advances in Childhood Leukemia Consortium
National Institutes of Health Clinical Center (CC)
University of Nebraska
Memorial Sloan Kettering Cancer Center
Eastern Cooperative Oncology Group
University of California, San Diego
Stanford University
Fred Hutchinson Cancer Center
Fred Hutchinson Cancer Center
National Institutes of Health Clinical Center (CC)
University of Washington
Medical College of Wisconsin
Fred Hutchinson Cancer Center
Nohla Therapeutics, Inc.
Stanford University
Stanford University
National Institutes of Health Clinical Center (CC)
Dartmouth-Hitchcock Medical Center
Masonic Cancer Center, University of Minnesota
Masonic Cancer Center, University of Minnesota
Children's Oncology Group
Fred Hutchinson Cancer Center
Fred Hutchinson Cancer Center
Fred Hutchinson Cancer Center
Fred Hutchinson Cancer Center
Fred Hutchinson Cancer Center
Fred Hutchinson Cancer Center
Fred Hutchinson Cancer Center
Fred Hutchinson Cancer Center
Fred Hutchinson Cancer Center
Fred Hutchinson Cancer Center
Roswell Park Cancer Institute
Fred Hutchinson Cancer Center
Fred Hutchinson Cancer Center
Fred Hutchinson Cancer Center
Stanford University
Fred Hutchinson Cancer Center
Stanford University
National Institutes of Health Clinical Center (CC)
Dana-Farber Cancer Institute
Case Comprehensive Cancer Center